Miri Yavzori

Optimizing Anti-TNF-α Therapy: Serum Levels of Infliximab and Adalimumab Are Associated With Mucosal Healing in Patients With Inflammatory Bowel Diseases

Bella Ungar, Idan Levy, Yarden Yavne et al. · Clinical Gastroenterology and Hepatology · 2015 · 363 citations

Veterinary Medicine, Immunology, Pharmacotherapy +17

Addition of an Immunomodulator to Infliximab Therapy Eliminates Antidrug Antibodies in Serum and Restores Clinical Response of Patients With Inflammatory Bowel Disease

Shomron Ben‐Horin, Matti Waterman, Uri Kopylov et al. · Clinical Gastroenterology and Hepatology · 2012 · 304 citations

Medicine, Immunology, Pharmacology +16

The temporal evolution of antidrug antibodies in patients with inflammatory bowel disease treated with infliximab

Bella Ungar, Yehuda Chowers, Miri Yavzori et al. · Gut · 2013 · 303 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults

Dani Cohen, Shai Ashkenazi, Manfred S. Green et al. · The Lancet · 1997 · 260 citations

Veterinary Medicine, Immunology, Infectious Diseases +11

The immunogenic part of infliximab is the F(ab')2, but measuring antibodies to the intact infliximab molecule is more clinically useful

Shomron Ben‐Horin, Miri Yavzori, Lior H. Katz et al. · Gut · 2010 · 205 citations

Life Sciences, Immunology, Clinical Immunology +15